Quidel | QDEL - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.65B 787M 2026-06
Agilent USD 1.04B 52M 2026-06
Becton, Dickinson and Co. USD 2.32B 161M 2026-06
Bruker USD 416M 36.2M 2026-06
Cerus USD 33.33M 8.66M 2024-12
Charles River Laboratories USD 348.78M 69.47M 2026-06
Danaher USD 3.61B 20M 2026-06
Haemonetics USD 202.8M 4.59M 2026-06
Illumina USD 770M 49M 2026-06
IQVIA Holdings USD 1.44B 368M 2026-06
Merit Medical Systems USD 215.17M 30.37M 2026-06
Mettler Toledo International USD 555.82M 119.62M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
Neogen USD 99M 7.7M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Quidel USD 223.9M 315.7M 2026-06
Revvity USD 416.87M 29.21M 2026-06
STAAR Surgical USD 69.73M 868K 2026-06
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Waters USD 490M 52M 2026-06